Glimfirst MV 1mg/500mg/0.2mg Tablet SR

By Glimfirst MV

Rx

15 Tablet SR in a Strip

Composition icon

Composition

Glimepiride(1mg) + Metformin(500mg) + Voglibose(0.2mg)

Manufacturer - Sinsan Pharmaceuticals icon

Manufacturer - Sinsan Pharmaceuticals

102-103, Park Plaza, Opp. Kamla Nehru Park, Off. Bhandarkar Road, Deccan Gymkhana, Pune, Maharashtra 411004

Expires on or after icon

Expires on or after

October, 2025

About Glimfirst MV 1mg/500mg/0.2mg Tablet SR

Glimfirst MV 1mg/500mg/0.2mg Tablet SR falls under the category of anti-diabetic medications, specifically designed to address type 2 diabetes mellitus in adults. This medication plays a crucial role in regulating blood sugar levels in individuals living with diabetes. To maximize its effectiveness, it is recommended to take Glimfirst MV 1mg/500mg/0.2mg Tablet SR with food consistently at the same time daily. The appropriate dosage will be determined by your doctor based on its impact on your blood sugar levels, which may be adjusted periodically.

Consistency in taking Glimfirst MV 1mg/500mg/0.2mg Tablet SR is paramount even if you feel well or if your blood sugar levels seem controlled. Abruptly discontinuing this medication without professional consultation can lead to an elevation in blood sugar levels, posing risks such as kidney damage, vision impairment, nerve complications, and even limb loss. It is essential to recognize that this medication is only a component of a comprehensive treatment plan that should include a balanced diet, regular physical activity, and weight management under your doctor's guidance. Lifestyle modifications significantly contribute to diabetes management.

The primary side effect associated with Glimfirst MV 1mg/500mg/0.2mg Tablet SR is hypoglycemia, characterized by low blood glucose levels. Awareness of symptoms like sweating, dizziness, headache, and trembling is crucial for timely intervention. Maintaining regular meals and carrying a quick-acting glucose source, such as sugary snacks or fruit juice, can help prevent hypoglycemia. Consumption of alcohol can elevate the risk of low blood sugar levels and should be avoided. Additional side effects may include taste alterations, nausea, diarrhea, stomach discomfort, headache, swelling, vision disturbances, bone fractures, and upper respiratory infections. Some individuals may experience weight gain while on this medication.

Glimfirst MV 1mg/500mg/0.2mg Tablet SR is contraindicated in individuals with type 1 diabetes mellitus, diabetic ketoacidosis, or severe kidney or liver disorders. Prior to initiating this medication, inform your doctor if you have a history of heart disease, as it may not be suitable in such cases. Pregnant or nursing women should seek medical advice before starting this treatment. Routine monitoring of blood sugar levels is necessary, and periodic blood tests may be recommended to evaluate blood cell counts and liver functionality as part of the monitoring process.


Benefits

Glimfirst MV 1mg/500mg/0.2mg Tablet SR offers several benefits in the treatment of Type 2 diabetes mellitus. This medication plays a crucial role in controlling high blood glucose levels, which is essential in managing diabetes effectively. By slowing down the breakdown of food in the intestine to simple glucose,Glimfirst MV 1mg/500mg/0.2mg Tablet SR helps to decrease the sudden spikes in blood sugar levels after meals. Additionally, it facilitates the elimination of excess glucose from the body through urine.


Maintaining optimal blood glucose levels is vital as it significantly lowers the risk of developing serious complications associated with diabetes, such as kidney damage, eye damage, nerve problems, and the potential loss of limbs. Moreover, individuals with Type 2 diabetes who also have cardiovascular disease can benefit from Glimfirst MV 1mg/500mg/0.2mg Tablet SR as it reduces the risk of mortality from heart-related issues.


By incorporating Glimfirst MV 1mg/500mg/0.2mg Tablet SR into your daily routine alongside a balanced diet and regular exercise, you can lead a normal and healthy life. It is important to adhere to the prescribed regimen consistently to ensure continuous protection of your future health. This medication is a valuable tool in the management of Type 2 diabetes, offering not only immediate benefits in controlling blood sugar levels but also long-term advantages in preventing severe complications and enhancing overall well-being.


How to use the Glimfirst MV 1mg/500mg/0.2mg Tablet SR

To use Glimfirst MV 1mg/500mg/0.2mg Tablet SR, follow your doctor's instructions on dosage and duration. Swallow the tablet whole without chewing, crushing, or breaking it. It is important to take Glimfirst MV 1mg/500mg/0.2mg Tablet SR on an empty stomach. Make sure to adhere to the prescribed dose and duration provided by your doctor for the best results. If you have any questions or concerns about using this medication, consult your healthcare provider for guidance.


Uses of Glimfirst MV 1mg/500mg/0.2mg Tablet SR

Glimfirst MV 1mg/500mg/0.2mg Tablet SR is mainly used for managing Type 2 diabetes mellitus. This medication helps in controlling blood sugar levels in individuals with this condition. It is prescribed by healthcare professionals to help patients maintain healthy blood sugar levels. By following the recommended dosage, Glimfirst MV 1mg/500mg/0.2mg Tablet SR can be effective in the treatment of Type 2 diabetes mellitus.


What conditions Glimfirst MV 1mg/500mg/0.2mg Tablet SR treats?

Glimfirst MV 1mg/500mg/0.2mg Tablet SR is a medication used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes by slowing down the breakdown of food into glucose, reducing the rise in blood sugar levels after meals, and eliminating excess glucose through urine. Managing blood glucose levels is crucial in preventing serious complications of diabetes such as kidney damage, eye problems, nerve issues, and limb loss. Regular use, along with a healthy diet and exercise, can help individuals with diabetes lead a normal and healthy life.


Should you consult a doctor?

Seek medical attention immediately if you experience persistent and severe side effects such as hypoglycemia, which can lead to symptoms like sweating, dizziness, headache, and shaking. Consult your doctor if you have concerns about common side effects like nausea, diarrhea, abdominal pain, or loss of appetite. Additionally, if you have type 1 diabetes, diabetic ketoacidosis, severe kidney or liver disease, or a history of heart disease, do not take Glimfirst MV 1mg/500mg/0.2mg Tablet SR without consulting your doctor first. Pregnant or breastfeeding women should also seek medical advice before starting this medication. Regular monitoring of blood sugar levels and potential side effects is essential, so keep in touch with your healthcare provider and follow their guidance closely. Any unusual symptoms or changes in your health should be reported to your doctor promptly for proper evaluation and management.


Side effects of Glimfirst MV 1mg/500mg/0.2mg Tablet SR

When taking Glimfirst MV 1mg/500mg/0.2mg Tablet SR, some common side effects may occur. These side effects are generally mild and may go away as your body gets used to the medication. However, if these side effects persist or if you are concerned about them, it is important to consult your doctor. Common side effects of Glimfirst MV 1mg/500mg/0.2mg Tablet SR include nausea, diarrhea, abdominal pain, hypoglycemia (low blood glucose level), and loss of appetite. If you experience any of these side effects and they are bothersome or persistent, seek medical advice to address your concerns. It is essential to monitor and communicate any side effects with your healthcare provider for appropriate guidance and support.


Safety advice

scroll

liver

Glimfirst MV 1mg/500mg/0.2mg Tablet SR should be used carefully in individuals with liver issues. It may be necessary to adjust the dosage of Glimfirst MV 1mg/500mg/0.2mg Tablet SR in such cases. It is advised to seek guidance from your healthcare provider before using this medication. Typically, Glimfirst MV 1mg/500mg/0.2mg Tablet SR is initiated at a low dose for patients with mild to moderate liver problems. However, it is not recommended for use in individuals with severe liver disease.

scroll

kidney

Glimfirst MV 1mg/500mg/0.2mg Tablet SR may not be safe for patients with kidney disease and is not recommended for those with severe kidney issues. Consult your doctor before use.

scroll

alcohol

It is unsafe to consume alcohol with Glimfirst MV 1mg/500mg/0.2mg Tablet SR. Avoid alcohol when taking this medication. Caution - Pregnancy It is important to consult your doctor regarding alcohol consumption with Glimfirst MV 1mg/500mg/0.2mg Tablet SR during pregnancy.

scroll

driving

To ensure safety, avoid driving if experiencing low or high blood sugar symptoms while taking Glimfirst MV 1mg/500mg/0.2mg Tablet SR.

scroll

pregnancy

Glimfirst MV 1mg/500mg/0.2mg Tablet SR may be harmful during pregnancy based on animal studies. Consult your doctor to assess potential risks and benefits before using it.

scroll

breastfeeding

Glimfirst MV 1mg/500mg/0.2mg Tablet SR is likely unsafe during breastfeeding. Limited data indicates it may pass into breastmilk and harm the baby.


Consumption warning before consuming Glimfirst MV 1mg/500mg/0.2mg Tablet SR

Before consuming Glimfirst MV 1mg/500mg/0.2mg Tablet SR, it's essential to note several crucial points. Firstly, always take this medication with food and at the same time daily for optimal results. Your doctor will determine the appropriate dosage based on your blood sugar levels, which may require adjustments over time. Even if you feel fine or your blood sugar is under control, continue taking the medicine as stopping abruptly could lead to elevated blood sugar levels, posing risks such as kidney damage, blindness, nerve issues, or limb loss.


Remember, Glimfirst MV 1mg/500mg/0.2mg Tablet SR may cause low blood sugar levels (hypoglycemia) as a common side effect. Be attentive to symptoms like sweating, dizziness, headache, or shaking and have fast-acting glucose sources on hand. Moreover, avoid alcohol consumption as it can escalate the risk of low blood sugar. Additional side effects might include taste changes, nausea, diarrhea, or blurred vision. Notably, this medication is not suitable for individuals with type 1 diabetes, diabetic ketoacidosis, severe kidney or liver disease, or a history of heart problems. If pregnant or breastfeeding, consult a healthcare provider before using Glimfirst MV 1mg/500mg/0.2mg Tablet SR. Regular monitoring of blood sugar levels is vital, along with periodic blood tests to assess blood cell counts and liver function.


What if you forgot to take Glimfirst MV 1mg/500mg/0.2mg Tablet SR?

If you forget to take your Glimfirst MV 1mg/500mg/0.2mg Tablet SR, try to take it as soon as you remember. But if it's nearly time for your next dose, just skip the missed one and stick to your usual dosage routine. Remember not to double up on doses to make up for the one you missed.


Related lab tests

For patients taking Glimfirst MV 1mg/500mg/0.2mg Tablet SR, related lab tests may include Glucose - Fasting Blood, Glucose - Postprandial Blood, and Glycosylated Hemoglobin. These tests are important to monitor blood sugar levels and the overall effectiveness of the medication in managing diabetes. Glucose - Fasting Blood test measures the sugar levels in the blood after fasting for a certain period of time, providing insights into how the body processes glucose without food intake. The Glucose - Postprandial Blood test, on the other hand, measures blood sugar levels after a meal, indicating how the body handles glucose after eating. Lastly, the Glycosylated Hemoglobin test, also known as HbA1c test, gives an average of blood sugar levels over the past 2-3 months, offering a long-term view of blood sugar control. Regular monitoring of these lab tests can help healthcare providers tailor treatment plans for individuals taking Glimfirst MV 1mg/500mg/0.2mg Tablet SR to better manage their diabetes.


Additional Information

Habit FormingNo
Chemical Class-
Therapeutic ClassANTI DIABETIC
Action Class-

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

141

Inclusive of all taxes

Content verified by

chevron-right

Dr. Upasana Bhatia

MBBS - General Medicine

Last update on 01-Oct-2024